Stay updated on Dolatav Clinical Trial: Nucleoside Sparing in HIV-1
Sign up to get notified when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.

Latest updates to the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedSite update to Revision: v3.4.2; the previous funding notice and Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check23 days agoChange DetectedA site-wide notice about government funding lapse and NIH operating status was added, and the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check31 days agoChange DetectedAdded a 'Show glossary' option and new metadata fields including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision label 'v3.4.0'. Removed the older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the previous revision label 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision: v3.3.4 is now displayed and Revision: v3.3.3 has been removed. This appears to be a minor version label update rather than substantive content.SummaryDifference0.1%

- Check66 days agoChange DetectedFooter now displays 'Revision: v3.3.3'. The HHS Vulnerability Disclosure link and the previous 'Revision: v3.3.2' entry were removed.SummaryDifference0.1%

- Check94 days agoChange DetectedThe Publications section now includes a note stating that publications are provided voluntarily by the person entering information and pertain to the study results. The revision tag was updated to v3.3.2, replacing v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Dolatav Clinical Trial: Nucleoside Sparing in HIV-1
Enter your email address, and we'll notify you when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.